Sagimet Biosciences (SGMT) Times Interest Earned (2022 - 2026)
Sagimet Biosciences' (SGMT) quarterly Times Interest Earned came in at -$5.88 in Q1 2026, up 99.23% year-on-year from -$2.95 in Q1 2025, and down 107.4% quarter-over-quarter from -$2.83 in Q4 2025.
Sagimet Biosciences (SGMT) Times Interest Earned (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$5.88 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 99.23% year-over-year to -$5.88 in Q1 2026; TTM through Mar 2026 was -$24.45, a 99.03% increase from a year earlier, with the FY2025 full-year figure at -$14.97, down 1725.74% from the prior year.
- Times Interest Earned declined to -$5.88 in Q1 2026 per SGMT's latest filing, from -$2.83 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.17 in Q4 2023 and bottomed at -$1096.0 in Q1 2024.
- The 5-year median for Times Interest Earned is -$1.94 (2025), against an average of -$172.59.
- Across the five-year window, Times Interest Earned sank 59122.35% in 2024 and surged 99.44% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$1.85 in 2022, then soared by 90.71% to -$0.17 in 2023, then slumped by 59.57% to -$0.27 in 2024, then plunged by 933.96% to -$2.83 in 2025, then slumped by 107.4% to -$5.88 in 2026.
- Per Business Quant, the three latest SGMT Times Interest Earned figures stand at -$5.88 (Q1 2026), -$2.83 (Q4 2025), and -$2.03 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Sagimet Biosciences | 227.27 Mn | 227.27 Mn | - | -5.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.88 |
| Dec 31, 2025 | -2.83 |
| Sep 30, 2025 | -2.03 |
| Jun 30, 2025 | -1.11 |
| Mar 31, 2025 | -764.04 |
| Dec 31, 2024 | -0.27 |
| Jun 30, 2024 | -196.09 |
| Mar 31, 2024 | -1,096.00 |
| Dec 31, 2023 | -0.17 |
| Sep 30, 2023 | -0.42 |
| Jun 30, 2023 | -0.33 |
| Dec 31, 2022 | -1.85 |